Holen Sie sich die Stockscreener-App
3.40
6.25%
0.20
Schlusskurs vom Vortag:
$3.20
Offen:
$3.33
24-Stunden-Volumen:
8,730
Relative Volume:
0.61
Marktkapitalisierung:
$3.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.29M
KGV:
-0.1395
EPS:
-24.3686
Netto-Cashflow:
$-6.81M
1W Leistung:
+5.70%
1M Leistung:
+16.84%
6M Leistung:
-1.73%
1J Leistung:
-65.97%
1-Tages-Spanne:
$3.205
$3.40
1-Wochen-Bereich:
$2.9737
$3.40
52-Wochen-Spanne:
$2.36
$13.50
Heartsciences Inc Stock (HSCS) Company Profile
Firmenname
Heartsciences Inc
Sektor
Branche
Telefon
682-237-7781
Adresse
550 RESERVE ST, SUITE 360, SOUTHLAKE
Vergleichen Sie HSCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.40 | 3.48M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
131.39 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
94.88 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
347.22 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.24 | 106.51B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.53 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Heartsciences Inc Aktie (HSCS) Neueste Nachrichten
Lifestyle Icon Martha Stewart Confirmed As Vivid Sydney 2025's Global Storyteller - Barchart.com
This AI Company Is Solving A 100+ Year-Old Health Problem - Barchart.com
Eagle Eye Appoints Chief Revenue Officer, Jeff Baskin, to Accelerate Growth in North America - Barchart.com
/R E P E A T -- LASSONDE INDUSTRIES INC. WILL HOLD A CONFERENCE CALL TO DISCUSS ITS Q4 AND FISCAL 2024 RESULTS/ - Barchart.com
HeartSciences faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada
HeartSciences faces Nasdaq delisting over equity shortfall - Investing.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results - The Manila Times
HeartSciences Reports Third Quarter Fiscal 2025 Financial Results and Business Update on AI-Powered ECG Innovations - Nasdaq
HeartSciences Q3: AI-ECG Breakthrough Nears FDA Milestone as CMS Backs Reimbursement - StockTitan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications - The Manila Times
AI Medical Tech Firm HeartSciences Strengthens Investor Communications Strategy - StockTitan
HeartSciences grants stock options to executives and directors - MSN
HeartSciences grants stock options to executives and directors By Investing.com - Investing.com South Africa
Becton, Dickinson And Company's Q1 2025 Earnings: What To Expect - Barchart.com
Scientists Discover Heart-Saving Powers in Olive, Grape, Garlic, Rosemary, and Saffron - SciTechDaily
HeartSciences Inc. withdraws IPO registration - Investing.com
HeartSciences Inc. withdraws IPO registration By Investing.com - Investing.com UK
Biogen Stock: Is BIIB Underperforming The Healthcare Sector? - Barchart.com
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - The Manila Times
HeartSciences Advances AI-Powered ECG Platform, FDA Submission Set for Q1 2025 - StockTitan
Anteris Technologies Prices $88.8M Nasdaq IPO for Revolutionary Heart Valve Development - StockTitan
Bill Otten Joins Hello Heart as Commercial President - Medical Product Outsourcing
David Chung Lands Top Job at Heart Repair Technologies - Medical Product Outsourcing
HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - The Manila Times
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewswire
HeartSciences Secures $125 Medicare Reimbursement for AI-ECG Tech, Awaits FDA Nod | HSCSW Stock News - StockTitan
HeartSciences shareholders approve auditor and meeting adjournment - Investing.com India
HeartSciences shareholders approve auditor and meeting adjournment By Investing.com - Investing.com UK
Clear Secure: Q3 Earnings Snapshot - Barchart.com
Investor Alert: Halo Collective, Inc. And Its Missing Continuous Disclosure Documents - Barchart.com
Heart Test Laboratories announces corporate name change to HeartSciences - Investing.com India
What To Expect From Pfizer's Q3 2024 Earnings Report - Barchart.com
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Earnings Preview: What To Expect From Intuitive Surgical's Report - Barchart.com
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket - Benzinga
Shares of HeartSciences get a bump from announcement of non-dilutive financing - Kursiv Media
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - GlobeNewswire
HeartSciences reports fiscal 2024 financial results - Medical Buyer
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency - GlobeNewswire
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - GlobeNewswire
HeartSciences Adds Another International Patent to its IP Portfolio - MPO-mag
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction - Diagnostic and Interventional Cardiology
Alexandria Real Estate Equities, Inc. Releases 2023 Corporate Responsibility Report Highlighting Its Longstanding Leadership at the Vanguard and Heart of the Life Science Industry - PR Newswire
Cardiomatics Cooperates with the Biotronik Sales Organization in Germany to Accelerate the Growth of its Leading AI-powered ECG Analysis Solution in the German Market - Diagnostic and Interventional Cardiology
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio - GlobeNewswire
HeartSciences’ MyoVista Wavelet Technology Now Protected in Canada - MPO-mag
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG - Diagnostic and Interventional Cardiology
Partho Sengupta Joins HeartSciences’ Scientific Advisory Board - MPO-mag
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias - Diagnostic and Interventional Cardiology
Finanzdaten der Heartsciences Inc-Aktie (HSCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.85%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):